These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19787817)

  • 1. One step at a time: identification and validation of biomarkers for nonalcoholic steatohepatitis.
    Talwalkar JA
    Hepatology; 2009 Oct; 50(4):1000-3. PubMed ID: 19787817
    [No Abstract]   [Full Text] [Related]  

  • 2. Is biopsy always necessary? Toward a clinico-laboratory approach for diagnosing nonalcoholic steatohepatitis in obesity.
    Emanuele E
    Hepatology; 2008 Dec; 48(6):2086-7; author reply 2087. PubMed ID: 19030167
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum cytokeratin-18 fragment level: a noninvasive biomarker for not only nonalcoholic steatohepatitis, but also alcoholic steatohepatitis.
    Li X; Zhang Y; Wu K; Fan D
    Hepatology; 2010 May; 51(5):1865-6. PubMed ID: 20041411
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum levels of CK18 M30 and leptin are useful predictors of steatohepatitis and fibrosis in paediatric NAFLD.
    Fitzpatrick E; Mitry RR; Quaglia A; Hussain MJ; DeBruyne R; Dhawan A
    J Pediatr Gastroenterol Nutr; 2010 Oct; 51(4):500-6. PubMed ID: 20808246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive diagnosis of nonalcoholic fatty liver disease using serum biomarkers.
    Mitry RR; De Bruyne R; Quaglia A; Hughes RD; Dhawan A
    Hepatology; 2007 Dec; 46(6):2047-8; author reply 2048. PubMed ID: 18046726
    [No Abstract]   [Full Text] [Related]  

  • 6. Keratin-18 as a marker of steatohepatitis.
    Gonzalez-Quintela A; Lojo S; Otero E; Perez LF
    Hepatology; 2007 Feb; 45(2):545. PubMed ID: 17256723
    [No Abstract]   [Full Text] [Related]  

  • 7. An apoptosis biomarker for prediction of nonalcoholic steatohepatitis.
    Bantel H; Bahr MJ; Schulze-Osthoff K
    Hepatology; 2009 Sep; 50(3):991. PubMed ID: 19593820
    [No Abstract]   [Full Text] [Related]  

  • 8. Validation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for prediction of liver injury in patients with morbid obesity.
    Lassailly G; Caiazzo R; Hollebecque A; Buob D; Leteurtre E; Arnalsteen L; Louvet A; Pigeyre M; Raverdy V; Verkindt H; Six MF; Eberle C; Patrice A; Dharancy S; Romon M; Pattou F; Mathurin P
    Eur J Gastroenterol Hepatol; 2011 Jun; 23(6):499-506. PubMed ID: 21499110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Commentary on "Cytokeratin 18, a Marker of Cell Death, is Increased in Children With Suspected Nonalcoholic Fatty Liver Disease".
    Yilmaz Y; Dolar E; Ulukaya E
    J Pediatr Gastroenterol Nutr; 2009 Sep; 49(3):371; author reply 371-2. PubMed ID: 19707105
    [No Abstract]   [Full Text] [Related]  

  • 10. Apoptosis in nonalcoholic steatohepatitis with normal aminotransferase values: zooming in on cytokeratin 18 fragments.
    Yilmaz Y; Kurt R; Kalayci C
    Biomark Med; 2010 Oct; 4(5):743-5. PubMed ID: 20945987
    [No Abstract]   [Full Text] [Related]  

  • 11. Will non-invasive markers replace liver biopsy for diagnosing and staging fibrosis in non-alcoholic steatohepatitis?
    Hashimoto E; Farrell GC
    J Gastroenterol Hepatol; 2009 Apr; 24(4):501-3. PubMed ID: 19368628
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum M30 levels: a potential biomarker of severe liver disease in nonalcoholic fatty liver disease and normal aminotransferase levels.
    Yilmaz Y; Ulukaya E; Dolar E
    Hepatology; 2009 Feb; 49(2):697; author reply 697. PubMed ID: 19035337
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum markers of hepatocyte apoptosis: current terminology and predictability in clinical practice.
    Tiniakos DG; Papatheodoridis GV
    Hepatology; 2010 Feb; 51(2):717-8. PubMed ID: 19918977
    [No Abstract]   [Full Text] [Related]  

  • 14. Apoptosis markers in liver biopsy of nonalcoholic steatohepatitis in pediatric patients.
    Valva P; De Matteo E; Galoppo M; Pedreira A; Giacove G; Lezama C; Marco I; Galoppo MC; Preciado MV
    Hum Pathol; 2008 Dec; 39(12):1816-22. PubMed ID: 18715620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Defragmenting" the noninvasive diagnosis of nonalcoholic steatohepatitis: hopes from cytokeratin-18.
    Yilmaz Y
    Hepatology; 2009 Sep; 50(3):990-1. PubMed ID: 19492431
    [No Abstract]   [Full Text] [Related]  

  • 16. An apoptosis panel for nonalcoholic steatohepatitis diagnosis.
    Tamimi TI; Elgouhari HM; Alkhouri N; Yerian LM; Berk MP; Lopez R; Schauer PR; Zein NN; Feldstein AE
    J Hepatol; 2011 Jun; 54(6):1224-9. PubMed ID: 21145805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic fatty liver disease activity score and Brunt's pathologic criteria for the diagnosis of nonalcoholic steatohepatitis: what do they mean and do they agree?
    Ballestri S; Lonardo A; Loria P
    Hepatology; 2011 Jun; 53(6):2142-3; author reply 2143. PubMed ID: 21618266
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum protein N-glycans profiling for the discovery of potential biomarkers for nonalcoholic steatohepatitis.
    Chen C; Schmilovitz-Weiss H; Liu XE; Pappo O; Halpern M; Sulkes J; Braun M; Cohen M; Barak N; Tur-Kaspa R; Vanhooren V; Van Vlierberghe H; Libert C; Contreras R; Ben-Ari Z
    J Proteome Res; 2009 Feb; 8(2):463-70. PubMed ID: 19140676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of hyaluronic acid and tissue metalloproteinase inhibitor-1 combined with age predict the presence of nonalcoholic steatohepatitis in a pilot cohort of subjects with nonalcoholic fatty liver disease.
    Miele L; Forgione A; La Torre G; Vero V; Cefalo C; Racco S; Vellone VG; Vecchio FM; Gasbarrini G; Rapaccini GL; Neuman MG; Grieco A
    Transl Res; 2009 Oct; 154(4):194-201. PubMed ID: 19766963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Robust detection of liver steatosis and staging of NAFLD by an improved ELISA for serum cytokeratin-18 fragments.
    Bantel H; John K; Schulze-Osthoff K
    Am J Gastroenterol; 2014 Jan; 109(1):140-1. PubMed ID: 24402545
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.